ArticleBioprocess and biosystems engineering2025
Biosynthesized ZnO-based bimetallic nanocomposite for anticancer, antimicrobial, and photocatalytic applications.
Article in Bioprocess and biosystems engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Green synthesis of ZnO/FeRSC advances · 2026Article
- Green-synthesized ZnO-MnO nanocomposite as a potent antimicrobial and antibiofilm agent: protein leakage mechanism and synergistic interaction with cefotaxime.Frontiers in microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Industrial wastewater, particularly antibiotic-laden effluents, poses a significant environmental threat, necessitating efficient and sustainable remediation strategies. In this study, ZnO/Au nanocomposites were synthesized using Urtica dioica extract (ZnO/Au@UDE NCs), offering an eco-friendly alternative to conventional chemical methods. The NCs exhibited well-defined spherical and oval morphologies (40-50 nm), as confirmed by FTIR, TEM, and XRD analyses. Their photocatalytic efficiency in degrading penicillin G was optimized by adjusting key parameters, achieving rapid degradation within 130 min. The incorporation of gold nanoparticles significantly enhanced the electron-hole separation, thereby improving photocatalytic performance. Furthermore, ZnO/Au@UDE NCs demonstrated potent antibacterial activity against Escherichia coli and Pseudomonas aeruginosa (MIC: 125 µg/ml) and exhibited strong antioxidant and anticancer properties, with IC50 values of 72.49 µg/ml for MCF-7 and 23.63 µg/ml for AGS cancer cells. The combined photocatalytic and biological functionalities highlight the potential of these NCs for environmental remediation and biomedical applications, demonstrating a sustainable and multifunctional approach to nanomaterial development.
Indexed as
Identifiers
40121599What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.